<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03178994</url>
  </required_header>
  <id_info>
    <org_study_id>317/60</org_study_id>
    <nct_id>NCT03178994</nct_id>
  </id_info>
  <brief_title>The Study of Efficacy and Safety of 2% Ketoconazole Cream in Thai Females With Mild Degree of Post - Adolescence Acne</brief_title>
  <official_title>The Study of Efficacy and Safety of 2% Ketoconazole Cream in Thai Females With Mild Degree of Post - Adolescence Acne</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study efficacy (total numbers of acne reduction) and safety of 2% Ketoconazole cream in
      Thai females with Mild degree Post-Adolescence acne comparing with placebo for a period of 12
      weeks.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total numbers of acne reduction</measure>
    <time_frame>10 weeks</time_frame>
    <description>the difference of acne count (total numbers of acne before treatment - total numbers of acne after treatment)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who achieve clear or almost clear after treatment</measure>
    <time_frame>10 weeks</time_frame>
    <description>clear or almost clear scored by Adult Female Acne Scoring Tool</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Post - Adolescence Acne</condition>
  <arm_group>
    <arm_group_label>2% ketoconazole cream</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2% ketoconazole cream apply on face twice daily for 10 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Hydrophilic cream (in-house preparation) apply on face twice daily for 10 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% ketoconazole cream</intervention_name>
    <description>2% ketoconazole cream applies twice daily</description>
    <arm_group_label>2% ketoconazole cream</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrophilic Cream</intervention_name>
    <description>Hydrophilic cream (in-house preparation) applies twice daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  regular menstrual cycle with mild degree of post - adolescence acne

          -  agree to stop topical and systemic medication for acne treatment for 2 and 4 weeks
             respectively.

        Exclusion Criteria:

          -  Pregnancy or lactation

          -  Other active rashes on faces.

          -  Allergic to ketoconazole or other ingredients of preparation.

          -  Signs of hyperandrogenism

          -  Taking anti-androgenic medications.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chanat Kumtornrut, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chulalongkorn University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chanat Kumtornrut, MD</last_name>
    <phone>+66814594965</phone>
    <email>chanat_1@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Natcha Chottawornsak, MD</last_name>
    <phone>+66879668899</phone>
    <email>natchaaa.nn@gmail.com</email>
  </overall_contact_backup>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2017</study_first_submitted>
  <study_first_submitted_qc>June 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2017</study_first_posted>
  <last_update_submitted>June 6, 2017</last_update_submitted>
  <last_update_submitted_qc>June 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Post - adolescence acne</keyword>
  <keyword>Topical 2% ketoconazole cream</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketoconazole</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

